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The symptoms of peripheral vascular disease are easily 
recognized by the clinician. Eighty percent of patients with 
intermittent claudication, the primary complaint of patients 
with superficial femoral artery stenosis or occlusion, remain 
in stable or improved condition with conservative manage- 
ment consisting of cessation of smoking and an exercise 
program (1.2); fewer than 7% will require amputation over a 
5 year period (3). Before the development of percutaneous 
transluminal angioplasty, bypass grafting was the surgical 
method of choice and was reserved for patients with more 
severe symptoms such as rest pain, gangrene and other signs 
of impending limb loss. A conservative surgical approach 
was favored because 5 year patency results were relatively 
low (50%) when synthetic grafts were used for limb salvage 
(4). Patency rates were improved when in situ saphenous 
veins were used for bypass grafting (5), but surgeons often 
prefer to reserve the saphenous veins for later coronary 
bypass surgery because most deaths (60% to 80%) in patients 
with peripheral vascular disease are due to coronary artery 
occlusions (3 ). 
Dotter and Judkins (6) introduced the concept of trans- 
luminal catheter treatment of vascular occlusions in 1964. 
Percutaneous balloon angioplasty (7) gained wide accept- 
ance. primarily among radiologists, who achieved results 
nearly as good as those for reverse saphenous vein grafts 
using a procedure that resulted in less mortality and morbid- 
ity and required a far shorter hospitalization period. Al- 
though stenoses and occlusions of short length can be 
treated with a 5 year patency rate of 80%, long-term occlu- 
sions >lO cm in length have proved more resistant to 
successful angioplasty (8-10). 
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The Laserprobe and other devices for angioplasty. One of 
the factors that interferes with successful angioplasty is 
passage of the guide wire and subsequent treatment hard- 
ware, in the plane between the atheroma and the media. The 
exact and somewhat varied location of this subintimal dis- 
section plane is elegantly demonstrated in the report by 
Tobis et al. (11). Their study. performed on amputated 
limbs, showed that guide wires and the Laserprobe device 
(Trimedyne Inc.) preferentially passed into this plane when 
deflected by a hard or calcified atheromatous plaque. 
Our own clinical experience with a wide variety of guide 
wires, exposed optical fibers for laser transmission (12) and 
the Laserprobe confirms this experimental finding. Any of 
these mechanical devices will be deflected toward the side of 
the vessel by a hard plaque. This deflection may be evident 
on fluoroscopy if the device tracks laterally along or beside 
the opacified vessel and is most readily detected utilizing 
digital road mapping. For this modification of fluoroscopy, 
an image of the contrast opacified vessel is stored in com- 
puter memory and displayed as a background image while 
the moving guide wire is superimposed on real time fluoros- 
copy. Oblique or lateral fluoroscopy is sometimes helpful to 
detect subintimal passage in planes anterior or posterior to 
the true lumen. Once the guide wire or Laserprobe enters 
this plane it may pass quite easily for several centimeters 
before reentering the lumen, tracking alongside a branch or 
perforating the vessel. Recognition of the entry of the guide 
wire into this subintimal plane requires experience and 
judicious use of small contrast injections to monitor its 
progress. 
With the use of combinations of steerable guide wires and 
catheters, it is often possible to withdraw the wire proxi- 
mally into the lumen and redirect it through the plaque into 
the distal lumen, thus preventing a potential technical fail- 
ure. Hydrophilic guide wires (such as the Glidewire [Medi- 
tech]) that are also steerable are especially useful in negoti- 
ating passage through the atheromatous obstruction, but are 
not immune to taking a subintimal course. In some instances 
the subintimal tract is short and the wire reenters the true 
lumen, permitting successful balloon angioplasty of the 
subintimal tract. When this tract is >l to 2 cm, however, it 
is unlikely that a balloon angioplasty will result in long-term 
patency. 
Devices to avoid perforation or early reocclusion. The 
Laserprobe is more difficult to direct and its stiffness en- 
hances passage into the subintimal plane as Tobis et al. (11) 
have shown. If laser energy is applied to heat the tip of the 
probe while it is in the subintimal plane, the likelihood of 
perforation is increased. This was also true in our early 
experience with open fibers where the direct laser light 
resulted in a high incidence of perforation as the fiber 
8 1989 by the American College of Cardiology 
15.56 WEXLER JACC Vol. 13, No. 7 
EDITORIAL COMMENT June 1989: 1555-7 
entered the subintimal plane. Newer devices are being tested 
to overcome this problem. In one, a balloon catheter is used 
to center the laser fiber (13). Another combines an atheroma 
detection sensor that interprets the fluorescence spectra 
patterns derived from the tissue illuminated by a probe laser 
before instructing the treatment laser to fire (14). The intent 
of this “probe and fire” device is to consistently treat only 
atheromatous tissue, leaving the media intact. 
Many of the newer angioplasty devices require initial 
passage of a guide wire or the creation of a small lumen in a 
previously occluded vessel. If the subintimal plane is en- 
tered, the operator will be faced with the problem of perfo- 
ration or early reocclusion by the partially displaced plaque 
closing the newly tunneled false lumen. The Simpson periph- 
eral atherectomy catheter (DVI) may solve this problem, 
even though the device itself may be located in the subin- 
timal tract, if the cutting surface can be directed against the 
hard, partially calcified plaque, removing it and the dissected 
intima. Our clinical experience with the high speed rotating 
atherectomy device, the Rotablator (Biophysics Interna- 
tional), which is placed over a guide wire, is that perforations 
predictably result when the device operates in a subintimal 
tract (1.5). Perforations are even more common with the 
Kensey rotating device (Cordis Corp.) (16). 
The likelihood of subintimal passage of angioplasty in- 
struments is particularly high in heavily calcified vessels that 
have been occluded for long periods of time. Although these 
conditions are typical for the relatively straight superficial 
femoral artery, an additional factor contributes to deflection 
of devices in curved or tortuous vessels. In these situations, 
the inability to steer the Laserprobe against the plaque and 
to maintain its central position when hard plaque deflects it 
into the subintimal plane is troublesome, especially in 
curved vessels, and will likely result in a failed angioplasty 
procedure. 
Laser versus balloon angioplasty. Does the Laserprobe 
offer any advantage over simple balloon angioplasty, partic- 
ularly when a hydrophilic guide wire is available? The 
overall results of Tobis, Sanborn and their coworkers (11,17) 
are no better than those from experienced centers perform- 
ing standard balloon angioplasty. We have found that some 
lesions that are impassable with guide wires may yield to the 
Laserprobe (in some cases used “cold,” without laser 
energy applied), but these few cases hardly justify the 
considerable expense of the laser equipment ($100,000 for 
purchase of the laser and >$500 for each disposable Laser- 
probe). 
Complications. Fortunately, failure to recanalize an oc- 
cluded superficial femoral artery with angioplasty techniques 
rarely worsens the clinical situation. Even perforation is 
usually well tolerated because there is minimal extravasation 
from a vessel with compromised flow. Hemorrhage from 
anterograde puncture of the femoral artery and the use of 
sheaths of 8 to 9F size can be a significant complication, 
particularly in obese patients. Meticulous technique and 
experience are necessary, and these are not acquired merely 
by familiarity with the retrograde approach to femoral artery 
puncture. An adequate training program, directed to the 
diagnosis and treatment of peripheral vascular disease and of 
~1 year’s duration should be mandatory. 
Indications. The clinical questions that demand our at- 
tention are: What are the indications for peripheral angio- 
plasty, and have these changed as a result of the introduction 
of adjunctive devices such as the Laserprobe? Angioplasty 
should be attempted, when the anatomy is favorable, in 
cases of threatened limb loss as an option to bypass surgery 
and to avoid amputation. Patients with severe intermittent 
claudication of >6 months’ duration, an ankle-brachial index 
~0.8 that decreases with exercise or a gradient >30 mm Hg 
between the upper thigh and calf are likely to have severe 
occlusive disease. Still, cessation of smoking and an exercise 
program yield symptomatic improvement, and vasodilator 
therapy may prove to be of additional benefit (18,19). Angio- 
plasty will be efficacious in 80% of such patients and may be 
attempted when maximal benefit from medical management 
fails to achieve a satisfactory quality of life. Because pro- 
longation of life or fear of dying from peripheral vascular 
disease are not clinically relevant considerations, the mere 
presence of occlusive disease is not an indication for inter- 
ventional therapy. Perhaps the most important lesson for the 
interventionalist is learning when not to intervene. 
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